RxDoctor Payments Data

Ryan Paulson, DO

Family Medicine · Greenville, SCNPI 1326575846

Payments from drug & device makers

$575in general payments, 2019–2025

Across 20 payments — averaging $28.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$217
  • Merck$180
  • Lilly USA, LLC$69
  • Sanofi Pasteur Inc.$47
  • Si-bone, Inc.$25
  • Abbott$22
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$575100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Nevro Corp.3$217
Merck9$180
Lilly USA, LLC3$69
Sanofi Pasteur Inc.2$47
Si-bone, Inc.1$25
Abbott1$22
Pfizer1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$575 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$19,359
Medicare patients
81
Services billed
190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide21$48,101
LinzessLinaclotide12$19,325
FarxigaDapagliflozin Propanediol12$16,182
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$5,488
Humalog Kwikpen U-100Insulin Lispro12$3,488
Rosuvastatin Calcium83$749
Levothyroxine Sodium59$712
Gabapentin21$585
Lisinopril80$573
Omeprazole23$541
Atorvastatin Calcium50$465
Nifedipine ErNifedipine20$400
Losartan Potassium39$364
Fluticasone Propionate24$297
Pantoprazole Sodium18$260

Paid to pharmacies, not to this prescriber.

Other family medicine in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →